Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 270

1.

A Repurposing Approach for Uncovering the Anti-Tubercular Activity of FDA-Approved Drugs with Potential Multi-Targeting Profiles.

Battah B, Chemi G, Butini S, Campiani G, Brogi S, Delogu G, Gemma S.

Molecules. 2019 Nov 29;24(23). pii: E4373. doi: 10.3390/molecules24234373.

PMID:
31795400
2.

Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists.

Matos MJ, Vilar S, Vazquez-Rodriguez S, Kachler S, Klotz KN, Buccioni M, Delogu G, Santana L, Uriarte E, Borges F.

J Med Chem. 2019 Dec 4. doi: 10.1021/acs.jmedchem.9b01572. [Epub ahead of print]

PMID:
31738058
3.

HLA-E-Restricted CD8+ T Lymphocytes Efficiently Control Mycobacterium tuberculosis and HIV-1 Co-Infection.

La Manna MP, Orlando V, Prezzemolo T, Di Carlo P, Cascio A, Delogu G, Poli G, Sullivan LC, Brooks AG, Dieli F, Caccamo N.

Am J Respir Cell Mol Biol. 2019 Nov 7. doi: 10.1165/rcmb.2019-0261OC. [Epub ahead of print]

PMID:
31697586
4.

Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history.

Magrì S, Paduano D, Chicco F, Cingolani A, Farris C, Delogu G, Tumbarello F, Lai M, Melis A, Casula L, Fantini MC, Usai P.

World J Gastroenterol. 2019 Oct 7;25(37):5676-5686. doi: 10.3748/wjg.v25.i37.5676.

PMID:
31602167
5.

Carbon nanomaterials: a new way against tuberculosis.

De Maio F, Palmieri V, De Spirito M, Delogu G, Papi M.

Expert Rev Med Devices. 2019 Oct;16(10):863-875. doi: 10.1080/17434440.2019.1671820. Epub 2019 Sep 30.

PMID:
31550943
6.

Honokiol, magnolol and its monoacetyl derivative show strong anti-fungal effect on Fusarium isolates of clinical relevance.

Oufensou S, Scherm B, Pani G, Balmas V, Fabbri D, Dettori MA, Carta P, Malbrán I, Migheli Q, Delogu G.

PLoS One. 2019 Sep 4;14(9):e0221249. doi: 10.1371/journal.pone.0221249. eCollection 2019.

PMID:
31483823
7.
8.

Case Report: Multifocal Tubercular Osteomyelitis of the Spine and Bilateral Dactylitis.

Taccari F, Baldin G, Emiliozzi A, Campana L, Tamburrini E, Leone E, Delogu G, Sali M, Cauda R, Leone A, Pallavicini F.

Am J Trop Med Hyg. 2019 Sep;101(3):494-497. doi: 10.4269/ajtmh.19-0262.

PMID:
31359856
9.

IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assay.

Palucci I, Battah B, Salustri A, De Maio F, Petrone L, Ciccosanti F, Sali M, Bondet V, Duffy D, Fimia GM, Goletti D, Delogu G.

Int J Med Microbiol. 2019 Jul;309(5):299-306. doi: 10.1016/j.ijmm.2019.05.005. Epub 2019 May 22.

PMID:
31147175
10.

A Storage-Dependent Platinum Functionalization with a Commercial Pre-Polymer Useful for Hydrogen Peroxide and Ascorbic Acid Detection.

Monti P, Migheli Q, Bartiromo AR, Pauciulo A, Gliubizzi R, Marceddu S, Serra PA, Delogu G.

Sensors (Basel). 2019 May 28;19(11). pii: E2435. doi: 10.3390/s19112435.

PMID:
31141953
11.

Discovery of new phthalazinones as vasodilator agents and novel pharmacological tools to study calcium channels.

Munín J, Quezada E, Viña D, Uriarte E, Delogu GL, Gil-Longo J.

Future Med Chem. 2019 Feb 25. doi: 10.4155/fmc-2018-0250. [Epub ahead of print]

PMID:
30801201
12.

HPV as a marker for molecular characterization in head and neck oncology: Looking for a standardization of clinical use and of detection method(s) in clinical practice.

Bussu F, Ragin C, Boscolo-Rizzo P, Rizzo D, Gallus R, Delogu G, Morbini P, Tommasino M.

Head Neck. 2019 Apr;41(4):1104-1111. doi: 10.1002/hed.25591. Epub 2019 Feb 12. Review.

PMID:
30747478
13.

Antifungal activity of oils macerates of North Sardinia plants against Candida species isolated from clinical patients with candidiasis.

Donadu MG, Usai D, Marchetti M, Usai M, Mazzarello V, Molicotti P, Montesu MA, Delogu G, Zanetti S.

Nat Prod Res. 2019 Jan 24:1-5. doi: 10.1080/14786419.2018.1557175. [Epub ahead of print]

PMID:
30676066
14.

Synthesis, molecular docking and cholinesterase inhibitory activity of hydroxylated 2-phenylbenzofuran derivatives.

Fais A, Kumar A, Medda R, Pintus F, Delogu F, Matos MJ, Era B, Delogu GL.

Bioorg Chem. 2019 Mar;84:302-308. doi: 10.1016/j.bioorg.2018.11.043. Epub 2018 Nov 29.

PMID:
30529848
15.

Targeting α -(1,4)-Glucosidase in Diabetes Mellitus Type 2: The Role of New Synthetic Coumarins as Potent Inhibitors.

Figueroa-Benavides C, Matos MJ, Peñaloza-Amion M, Veas R, Valenzuela-Barra G, Zapata G, Delogu G, Uriarte E, Santana L, Olea-Azar C, Delporte C.

Curr Top Med Chem. 2018;18(27):2327-2337. doi: 10.2174/1568026619666181130113033.

PMID:
30499400
16.

Vacuum-assisted closure (VAC®) systems and microbiological isolation of infected wounds.

Cozza V, Pepe G, Cintoni M, De Maio F, Tropeano G, Magalini S, Sganga G, Delogu G, Gui D.

World J Emerg Surg. 2018 Nov 20;13:53. doi: 10.1186/s13017-018-0216-z. eCollection 2018.

PMID:
30479652
17.

Successful analysis of a 100 years old semen stain generating a complete DNA STR profile.

Mameli A, Scudiero CM, Delogu G, Ghiani ME.

J Forensic Leg Med. 2019 Feb;61:78-81. doi: 10.1016/j.jflm.2018.11.008. Epub 2018 Nov 19.

PMID:
30476749
18.

Graphene oxide coatings prevent Candida albicans biofilm formation with a controlled release of curcumin-loaded nanocomposites.

Palmieri V, Bugli F, Cacaci M, Perini G, Maio F, Delogu G, Torelli R, Conti C, Sanguinetti M, Spirito M, Zanoni R, Papi M.

Nanomedicine (Lond). 2018 Nov;13(22):2867-2879. doi: 10.2217/nnm-2018-0183. Epub 2018 Nov 15.

PMID:
30431405
19.

The Mycobacterial HBHA Protein: A Promising Biomarker for Tuberculosis.

De Maio F, Squeglia F, Goletti D, Delogu G.

Curr Med Chem. 2019;26(11):2051-2060. doi: 10.2174/0929867325666181029165805. Review.

PMID:
30378481
20.

Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children.

Sali M, Buonsenso D, D'Alfonso P, De Maio F, Ceccarelli M, Battah B, Palucci I, Chiacchio T, Goletti D, Sanguinetti M, Valentini P, Delogu G.

J Infect. 2018 Dec;77(6):526-533. doi: 10.1016/j.jinf.2018.09.011. Epub 2018 Sep 26.

PMID:
30267797
21.

Vitamin D Levels in Active TB, Latent TB, Non-TB Pneumonia and Healthy Children: A Prospective Observational Study.

Buonsenso D, Sali M, Pata D, Masiello E, Salerno G, Ceccarelli M, Delogu G, Valentini P.

Fetal Pediatr Pathol. 2018 Oct;37(5):337-347. doi: 10.1080/15513815.2018.1509407. Epub 2018 Sep 27.

PMID:
30260729
22.

First description of agonist and antagonist IP-10 in urine of patients with active TB.

Petrone L, Bondet V, Vanini V, Cuzzi G, Palmieri F, Palucci I, Delogu G, Ciccosanti F, Fimia GM, Blauenfeldt T, Ruhwald M, Duffy D, Goletti D.

Int J Infect Dis. 2019 Jan;78:15-21. doi: 10.1016/j.ijid.2018.09.001. Epub 2018 Sep 7.

PMID:
30201505
23.

PE_PGRS3 of Mycobacterium tuberculosis is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in Mycobacterium smegmatis.

De Maio F, Battah B, Palmieri V, Petrone L, Corrente F, Salustri A, Palucci I, Bellesi S, Papi M, Rubino S, Sali M, Goletti D, Sanguinetti M, Manganelli R, De Spirito M, Delogu G.

Cell Microbiol. 2018 Dec;20(12):e12952. doi: 10.1111/cmi.12952. Epub 2018 Sep 26.

PMID:
30192424
24.

MAO inhibitory activity of bromo-2-phenylbenzofurans: synthesis, in vitro study, and docking calculations.

Delogu GL, Pintus F, Mayán L, Matos MJ, Vilar S, Munín J, Fontenla JA, Hripcsak G, Borges F, Viña D.

Medchemcomm. 2017 Jul 7;8(9):1788-1796. doi: 10.1039/c7md00311k. eCollection 2017 Sep 1.

PMID:
30108888
25.

Host Directed Therapies for Tuberculosis: Futures Strategies for an Ancient Disease.

Palucci I, Delogu G.

Chemotherapy. 2018;63(3):172-180. doi: 10.1159/000490478. Epub 2018 Jul 20. Review.

PMID:
30032143
26.

Genetic Diversity of Mycobacterium tuberculosis Isolates in the Metropolitan Area of Rome.

Cannas A, Camassa S, Sali M, Butera O, Mazzarelli A, Sanguinetti M, Di Caro A, Delogu G, Girardi E.

Chemotherapy. 2018;63(3):148-154. doi: 10.1159/000489860. Epub 2018 Jun 14.

PMID:
29902788
27.

Clinical isolates of the modern Mycobacterium tuberculosis lineage 4 evade host defense in human macrophages through eluding IL-1β-induced autophagy.

Romagnoli A, Petruccioli E, Palucci I, Camassa S, Carata E, Petrone L, Mariano S, Sali M, Dini L, Girardi E, Delogu G, Goletti D, Fimia GM.

Cell Death Dis. 2018 May 24;9(6):624. doi: 10.1038/s41419-018-0640-8.

PMID:
29795378
28.

Use of β-cyclodextrin as enhancer of ascorbic acid rejection in permselective films for amperometric biosensor applications.

Monti P, Rocchitta G, Marceddu S, Dettori MA, Fabbri D, Jaoua S, Migheli Q, Delogu G, Serra PA.

Talanta. 2018 Aug 15;186:53-59. doi: 10.1016/j.talanta.2018.04.034. Epub 2018 Apr 10.

PMID:
29784398
29.

Incidental intraoperative diagnosis of Mycobacterium abscessus meningeal infection: a case report and review of the literature.

Giovannenze F, Stifano V, Scoppettuolo G, Damiano F, Pallavicini F, Delogu G, Palucci I, Rapisarda A, Sturdà C, Pompucci A.

Infection. 2018 Oct;46(5):591-597. doi: 10.1007/s15010-018-1141-5. Epub 2018 Apr 23. Review.

PMID:
29687315
30.

Evaluation of Trypanocidal and Antioxidant Activities of a Selected Series of 3-amidocoumarins.

Moncada-Basualto M, Lapier M, Maya JD, Matsuhiro B, Olea-Azar C, Delogu GL, Uriarte E, Santana L, Matos MJ.

Med Chem. 2018;14(6):573-584. doi: 10.2174/1573406414666180419113437.

PMID:
29669503
31.

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease.

Kumar A, Pintus F, Di Petrillo A, Medda R, Caria P, Matos MJ, Viña D, Pieroni E, Delogu F, Era B, Delogu GL, Fais A.

Sci Rep. 2018 Mar 13;8(1):4424. doi: 10.1038/s41598-018-22747-2.

PMID:
29535344
32.

Synthesis of magnolol and honokiol derivatives and their effect against hepatocarcinoma cells.

Maioli M, Basoli V, Carta P, Fabbri D, Dettori MA, Cruciani S, Serra PA, Delogu G.

PLoS One. 2018 Feb 7;13(2):e0192178. doi: 10.1371/journal.pone.0192178. eCollection 2018.

PMID:
29415009
33.

In vitro activity of hybrid lavender essential oils against multidrug resistant strains of Pseudomonas aeruginosa.

Donadu M, Usai D, Pinna A, Porcu T, Mazzarello V, Fiamma M, Marchetti M, Cannas S, Delogu G, Zanetti S, Molicotti P.

J Infect Dev Ctries. 2018 Jan 31;12(1):9-14. doi: 10.3855/jidc.9920.

PMID:
31628828
34.

Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages.

Paolino M, Brindisi M, Vallone A, Butini S, Campiani G, Nannicini C, Giuliani G, Anzini M, Lamponi S, Giorgi G, Sbardella D, Ferraris DM, Marini S, Coletta M, Palucci I, Minerva M, Delogu G, Pepponi I, Goletti D, Cappelli A, Gemma S, Brogi S.

ChemMedChem. 2018 Mar 6;13(5):422-430. doi: 10.1002/cmdc.201700759. Epub 2018 Feb 14.

PMID:
29334428
35.

Coumarins as Promising Scaffold for the Treatment of Age-related Diseases - An Overview of the Last Five Years.

Delogu GL, Matos MJ.

Curr Top Med Chem. 2017;17(29):3173-3189. doi: 10.2174/1568026618666171215094029. Review.

PMID:
29243580
36.

Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection.

Palucci I, Matic I, Falasca L, Minerva M, Maulucci G, De Spirito M, Petruccioli E, Goletti D, Rossin F, Piacentini M, Delogu G.

J Intern Med. 2018 Mar;283(3):303-313. doi: 10.1111/joim.12714. Epub 2017 Dec 4.

PMID:
29205566
37.

PE and PPE Genes: A Tale of Conservation and Diversity.

Delogu G, Brennan MJ, Manganelli R.

Adv Exp Med Biol. 2017;1019:191-207. doi: 10.1007/978-3-319-64371-7_10. Review.

PMID:
29116636
38.

Evaluation of PE_PGRS33 as a potential surface target for humoral responses against Mycobacterium tuberculosis.

Minerva M, De Maio F, Camassa S, Battah B, Ivana P, Manganelli R, Sanguinetti M, Sali M, Delogu G.

Pathog Dis. 2017 Nov 30;75(8). doi: 10.1093/femspd/ftx100.

PMID:
28911035
39.

Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.

Chiacchio T, Delogu G, Vanini V, Cuzzi G, De Maio F, Pinnetti C, Sampaolesi A, Antinori A, Goletti D.

PLoS One. 2017 Aug 24;12(8):e0183846. doi: 10.1371/journal.pone.0183846. eCollection 2017.

PMID:
28837654
40.

Effects of alternative cropping systems on globe artichoke qualitative traits.

Spanu E, Deligios PA, Azara E, Delogu G, Ledda L.

J Sci Food Agric. 2018 Feb;98(3):1079-1087. doi: 10.1002/jsfa.8558. Epub 2017 Aug 28.

PMID:
28722756
41.

Impact of pe_pgrs33 Gene Polymorphisms on Mycobacterium tuberculosis Infection and Pathogenesis.

Camassa S, Palucci I, Iantomasi R, Cubeddu T, Minerva M, De Maio F, Jouny S, Petruccioli E, Goletti D, Ria F, Sali M, Sanguinetti M, Manganelli R, Rocca S, Brodin P, Delogu G.

Front Cell Infect Microbiol. 2017 Apr 21;7:137. doi: 10.3389/fcimb.2017.00137. eCollection 2017.

PMID:
28484686
42.

Understanding cutaneous tuberculosis: two clinical cases.

De Maio F, Trecarichi EM, Visconti E, Sanguinetti M, Delogu G, Sali M.

JMM Case Rep. 2016 Dec 16;3(6):e005070. doi: 10.1099/jmmcr.0.005070. eCollection 2016 Dec.

PMID:
28348793
43.

The Nutraceutical Dehydrozingerone and Its Dimer Counteract Inflammation- and Oxidative Stress-Induced Dysfunction of In Vitro Cultured Human Endothelial Cells: A Novel Perspective for the Prevention and Therapy of Atherosclerosis.

Profumo E, Buttari B, D'Arcangelo D, Tinaburri L, Dettori MA, Fabbri D, Delogu G, Riganò R.

Oxid Med Cell Longev. 2016;2016:1246485. doi: 10.1155/2016/1246485. Epub 2016 Dec 5.

PMID:
28050226
44.

Hydroxylated biphenyls as tyrosinase inhibitor: A spectrophotometric and electrochemical study.

Ruzza P, Serra PA, Fabbri D, Dettori MA, Rocchitta G, Delogu G.

Eur J Med Chem. 2017 Jan 27;126:1034-1038. doi: 10.1016/j.ejmech.2016.12.028. Epub 2016 Dec 13.

PMID:
28012343
45.

Low electro-synthesis potentials improve permselectivity of polymerized natural phenols in biosensor applications.

Monti P, Calia G, Marceddu S, Dettori MA, Fabbri D, Jaoua S, O'Neill RD, Migheli Q, Delogu G, Serra PA.

Talanta. 2017 Jan 1;162:151-158. doi: 10.1016/j.talanta.2016.10.019. Epub 2016 Oct 4.

PMID:
27837811
46.

Ruxolitinib therapy and telomere length in myelofibrosis.

Caocci G, Greco M, Delogu G, Secchi C, Perra A, Ghiani S, Orru F, Vacca A, Galimi F, La Nasa G.

Blood Cancer J. 2016 Oct 7;6(10):e479. doi: 10.1038/bcj.2016.91. No abstract available.

PMID:
27716743
47.

Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection.

Delogu G, Vanini V, Cuzzi G, Chiacchio T, De Maio F, Battah B, Pinnetti C, Sampaolesi A, Antinori A, Goletti D.

Scand J Immunol. 2016 Dec;84(6):344-352. doi: 10.1111/sji.12493.

PMID:
27636597
48.

Acanthamoeba castellanii Genotype T4 Stimulates the Production of Interleukin-10 as Well as Proinflammatory Cytokines in THP-1 Cells, Human Peripheral Blood Mononuclear Cells, and Human Monocyte-Derived Macrophages.

Mattana A, Sanna M, Cano A, Delogu G, Erre G, Roberts CW, Henriquez FL, Fiori PL, Cappuccinelli P.

Infect Immun. 2016 Sep 19;84(10):2953-62. doi: 10.1128/IAI.00345-16. Print 2016 Oct.

PMID:
27481240
49.

Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients.

Caocci G, Greco M, Delogu G, Secchi C, Martino B, Labate C, Abruzzese E, Trawinska MM, Galimberti S, Orru F, Fozza C, Gambacorti Passerini C, Galimi F, La Nasa G.

J Hematol Oncol. 2016 Jul 29;9(1):63. doi: 10.1186/s13045-016-0293-y.

PMID:
27473052
50.

Molecular Typing of Mycobacterium Tuberculosis Strains: A Fundamental Tool for Tuberculosis Control and Elimination.

Cannas A, Mazzarelli A, Di Caro A, Delogu G, Girardi E.

Infect Dis Rep. 2016 Jun 24;8(2):6567. doi: 10.4081/idr.2016.6567. eCollection 2016 Jun 24. Review.

PMID:
27403266

Supplemental Content

Loading ...
Support Center